CJC-1295 No DAC 10 mg lyophilised peptide vial with purple flip-off cap and white label

NovaPep

Buy CJC 1295 No DAC Australia: CJC-1295 No DAC 10mg Research Vial (Modified GRF 1-29)

$79AUD, GST included

In stock in Australia, batch certificate ready

Size: 10 mg vial

Certificate of analysis published for every batch
Third-party HPLC purity and MS identity testing
Dispatched same day before 3pm cut-off, tracked Australia-wide
Research use only, sold to adults aged 18 and over

Buy CJC 1295 no DAC online in Australia as a 10 mg research vial of Mod GRF 1-29, tested for identity and purity on every lot. CJC 1295 No DAC, also called Mod GRF (1-29), is a 29-residue GHRH analogue that retains the active core of growth hormone releasing hormone and activates the GHRH receptor on pituitary somatotrophs. Four substitutions slow enzymatic breakdown, D-alanine at 2, glutamine at 8, alanine at 15 and leucine at 27, and with no drug affinity complex attached its reported half-life sits around 30 minutes. The identity markers are C152H252N44O42 and 3367.9 g/mol, and mass spectrometry also tells it apart from the DAC version, which measures near 3647. HPLC testing is completed on every lot ahead of release. Keep the CJC-1295 and ipamorelin calculator handy when planning concentrations, and put ipamorelin in the same cart for GHRH and ghrelin synergy studies. Powder is shipped without diluent, so add bacteriostatic water, and store the unopened vial frozen at -20 °C in its carton. Supplied as a laboratory reagent, only to customers aged 18 or above.

For laboratory research use only. Not for human or veterinary use. Not TGA approved. See the NovaPep research use policy.

Mod GRF 1-29 Explained: What CJC-1295 No DAC Is

Mod GRF 1-29, the other common name for CJC-1295 No DAC, is a synthetic copy of the active leading segment of growth hormone releasing hormone. It is reworked with four amino acid changes so that it survives long enough for meaningful study. It activates the GHRH receptor, the same trigger the hypothalamus uses to signal the pituitary that it is time to release growth hormone. You can order CJC-1295 No DAC online in Australia as a 10 mg research vial, and every lot ships with its own certificate.

This is the short-acting member of the CJC-1295 family, the stabilised GHRH core without the albumin-binding arm. It is the amidated 29-residue chain only, a research reagent rather than a registered medicine.

Where Mod GRF 1-29 Comes From

Human GHRH was isolated in 1982 and is 44 amino acids long, yet its first 29 residues are sufficient to activate the receptor. That fragment, GRF 1-29, became sermorelin. Dipeptidyl peptidase-4 cleaves it within minutes. Modified GRF (1-29) solves that problem with four substitutions. The CJC label comes from ConjuChem, the Canadian firm that went on to add a drug affinity complex and create the long-acting form.

The tetrasubstituted chain is effectively ConjuChem's CJC-1295 without the additional C-terminal lysine that holds the albumin-reactive maleimide group. It was never taken forward as a medicine of its own, so CJC-1295 No DAC is really a trade label borrowed from the conjugated compound.

What Each Substitution Fixes

Each of the four changes addresses a particular weakness in the native sequence. Knowing their roles makes certificates and older papers easier to interpret.

D-alanine at position 2 is a mirror-image residue that DPP-4 cannot cut, so the first two residues stay attached.
Glutamine replaces asparagine at position 8, because asparagine gradually deamidates in water and alters both charge and mass.
Alanine replaces glycine at position 15, since alanine supports the helical shape the receptor reads.
Leucine replaces methionine at position 27, as methionine oxidises readily while leucine is a close size match that does not.

CJC-1295 No DAC at a Glance

Parent hormone: human GHRH, using the first 29 of its 44 residues
Changes: D-Ala2, Gln8, Ala15 and Leu27
Mass: 3367.9 g/mol, with no albumin linker
Reported half-life: around 30 minutes
Receptor: the GHRH receptor, signalling through Gs and cAMP

How CJC-1295 No DAC Works in the GHRH Pathway

Neurons in the arcuate nucleus secrete GHRH into the tiny portal vessels supplying the anterior pituitary. There it attaches to a class B G protein coupled receptor on somatotrophs. That receptor works through Gs, raising cyclic AMP, after which protein kinase A drives both the release of stored growth hormone and the production of fresh hormone.

Somatostatin opposes this via Gi, so the pulsatile pattern of growth hormone reflects an ongoing tug of war between the two inputs. The little mouse, a dwarf strain whose features stem from a single amino acid change in the GHRH receptor, shows just how much depends on this receptor.

Because the No DAC form works for about 30 minutes, it keeps the natural pulse pattern intact and clears between sampling points. Labs prefer it to native sermorelin when they want the same receptor target with enough stability to last through a complete sampling window in plasma or culture medium.

CJC-1295 No DAC Research: What Is Known and What Is Not

The literature has a real gap here. Few published studies examine the CJC 1295 no DAC molecule on its own. Much of the clinical data carrying the CJC name relates to the albumin-bound conjugate, and most short-acting human data relate to sermorelin, the unmodified fragment. Mod GRF falls between them, and any design relying on it should state that clearly in its methods. Labs planning similar studies can order CJC-1295 No DAC online in Australia, with identity and purity confirmed on every lot.

A common research use pairs it with a ghrelin receptor agonist such as ipamorelin. That combination is used to examine how the two pathways together shape growth hormone pulses in pituitary cells and animal models. Our CJC-1295 and ipamorelin safety research guide collects what the human trials documented.

Designing a Pituitary Cell Experiment

A practical suggestion is to measure cyclic AMP alongside secreted growth hormone. The cAMP response shows up within minutes and produces a cleaner concentration curve. With forskolin as a positive control it reveals whether a weak result comes from the receptor or from the cells. The complete DAC and No DAC comparison sets out how it contrasts with the long-acting relative.

CJC-1295 No DAC Specifications

Product name	CJC-1295 No DAC (Modified GRF 1-29)
Size	10 mg lyophilised vial
Structure	GHRH (1-29) amide carrying D-Ala2, Gln8, Ala15 and Leu27, with no DAC attached
Residue count	29 amino acids
Formula	C152H252N44O42
Molar mass	3367.9 g/mol
Physical form	White lyophilised cake inside a sealed 3 mL glass vial, purple cap, label printed with No DAC
Quality testing	Identity by mass spectrometry, which separates No DAC from DAC, plus HPLC purity and a certificate for each lot
In the box	A single 10 mg vial of CJC-1295 No DAC with no solvent, bacteriostatic water sold separately
Storage conditions	Closed vial at -20 °C away from light, then 2 to 8 °C after reconstitution
Stock status	In stock
Intended use	In vitro laboratory research only

Each unit is one vial holding 10 mg of Mod GRF (1-29) as a dried white cake, labelled No DAC so it cannot be mixed up with the 5 mg albumin-binding relative. There is no premix and no second peptide in the glass.

Why No CAS Number Is Shown

This page deliberately shows no CAS number. The number often quoted for this molecule, 863288-34-0, actually belongs to the DAC version, and leaving the row blank is better than printing an incorrect value. Identity is confirmed instead by the measured mass, close to 3367.9 g/mol, and by the sequence stated on the certificate.

The mass result carries extra weight here, because plenty of vials on the market just say CJC-1295 and both forms look the same as powder. A reading around 3647 points to DAC material. Something in between hints at a truncated or incompletely deprotected chain that deserves scrutiny before use. Only proceed once the same report shows a satisfactory HPLC purity, filed by lot in our COA library. Any lab trying to identify the best CJC 1295 peptide should begin with that mass line.

Mixing and Storing Mod GRF 1-29

Order bacteriostatic water along with the vial. Allow the vial to warm to room temperature, let the diluent trickle down the glass, and turn it gently until clear rather than shaking. Adding 2 mL to the 10 mg vial gives a 5 mg/mL solution, and the general peptide calculator handles any other volume. Order CJC-1295 No DAC online in Australia and it travels by tracked Australia Post from our local stock.

In solution Mod GRF (1-29) is less robust than as a dry powder, and its resistance to DPP-4 offers no defence against slow hydrolysis in water. Store sealed vials at -20 °C, keep the prepared solution at 2 to 8 °C in aliquots, and use each portion promptly.

CJC-1295 No DAC Compared With DAC, and Pairing With Ipamorelin

When choosing between CJC 1295 DAC or no DAC, let the time scale decide. The No DAC form works for about 30 minutes and clears between sampling points. CJC-1295 With DAC, sold as a 5 mg vial, attaches to albumin and stretches activity across several days, which suits designs requiring a sustained rise. The chemistry is covered in depth in our CJC-1295 DAC vs No DAC guide.

For ghrelin and GHRH synergy work, ipamorelin is the best peptide to stack with CJC 1295. Ipamorelin CJC-1295 No DAC studies generally begin with separate vials so each quantity can be set independently. The CJC-1295 No DAC Ipamorelin blend fits a ratio already fixed at equal amounts.

Other Names for CJC-1295 No DAC

You may see this compound sold as CJC-1295 No DAC, CJC 1295 without DAC, Modified GRF (1-29), Mod GRF 1-29 or tetrasubstituted GRF (1-29). The overlap with sermorelin, GRF (1-29) and GHRH (1-44) accounts for the tangle of names. Only the non-conjugated chain with four substitutions matches the contents of this vial.

Associated receptor terms such as GHRH-R, somatotroph, cAMP and protein kinase A describe the pathway it switches on in pituitary cells. Some sellers write only CJC-1295, which leaves room for confusion, whereas our label always says No DAC.

Buy CJC 1295 No DAC Online in Australia

Can you legally buy CJC 1295 in Australia?

The naming here is a little curious. The Poisons Standard entry reading "CJC-1295" carries CAS 863288-34-0, the DAC version, so strictly speaking it does not describe this molecule. In practice that matters little. As of October 2026, the June 2026 Poisons Standard lists growth hormone releasing hormones (GHRHs) as a class in Schedule 4, prescription only, and in Appendix D, clause 5. Under that clause, possession without authority is illegal.

Mod GRF (1-29) is plainly a GHRH analogue. The ARTG holds no product containing it, while sermorelin, its unmodified parent fragment, has its own named entry in Schedule 4. Anti-doping rules are just as broad. The 2026 WADA list places CJC-1295, sermorelin and tesamorelin together as GHRH analogues under S2, banned at all times, and athletes tested by Sport Integrity Australia are bound by it.

NovaPep holds CJC-1295 No DAC for sale in Australian stock strictly as a research reagent, alongside related analogues in our growth hormone peptides collection. Buyers must be 18 or over and complete the research-use declaration at checkout, and the vial is not for human or veterinary use. There is one fill, a 10 mg vial, twice the peptide of the 5 mg DAC vial, which helps pulsatile designs that consume material faster.

Order the whole study series together so every vial comes from one lot under one certificate. There is no need for a local reseller. This online store serves laboratories throughout Australia from one domestic stock and ships every order placed before the 3pm weekday cut-off on the same day. Once the parcel is on its way, follow it on the order tracking page.

CJC-1295 No DAC at a Glance

A strengthened GHRH fragment

CJC-1295 No DAC reproduces the first 29 residues of the hormone that signals the pituitary to release growth hormone, with four changed amino acids making it sturdier than the natural version.

Gs, cAMP and a short pulse

It activates the GHRH receptor on somatotrophs, raising cyclic AMP, and clears in about 30 minutes so natural pulses stay intact.

Pulse and synergy research

Used to study bursts of growth hormone release and how they interact with the ghrelin pathway in cells or animals. For laboratory research only.

Compared with the DAC form

CJC-1295 With DAC binds albumin and stays active for days, whereas the No DAC form behaves like a short signal lasting about 30 minutes.

Mix gently, store cold

Keep the closed vial frozen and the solution refrigerated in small portions. Dissolve by slowly turning the vial, not by shaking.

Buy the 10 mg vial online

One sealed 10 mg vial from Australian stock, with mass spectrometry confirming the No DAC molecule and HPLC recording purity.

CJC-1295 No DAC FAQ

What is CJC-1295 No DAC?

It is Mod GRF (1-29), the first 29 residues of growth hormone releasing hormone with four substitutions that resist enzyme breakdown and oxidation. It activates the GHRH receptor on pituitary somatotrophs and, without a drug affinity complex, has a reported half-life of around 30 minutes.

Should I order CJC-1295 No DAC or With DAC?

Go with No DAC to study discrete growth hormone pulses or to pair with a ghrelin agonist such as ipamorelin, as its activity fades within roughly 30 minutes. Choose CJC-1295 With DAC, a 5 mg vial, only if your design calls for a sustained rise over several days.

Why does CJC-1295 No DAC have no CAS number listed?

The number usually quoted, 863288-34-0, actually belongs to the DAC version, and we would rather leave the row out than display a wrong figure. Identity is shown instead by the measured mass of roughly 3367.9 g/mol and by the sequence on each lot certificate.

What does CJC 1295 No DAC ipamorelin research investigate?

It combines a short-acting GHRH receptor agonist with a ghrelin receptor agonist to examine how the two pathways together shape growth hormone pulses in pituitary cells and animal models. Both peptides are supplied only for laboratory and in vitro research, never for human or veterinary use. If you want both in one vial, the premixed CJC-1295 No DAC+Ipamorelin blend holds 5 mg of each.

Is a certificate of analysis provided with CJC-1295 No DAC?

Yes. Every lot is sent to an outside laboratory, where a measured mass near 3367.9 g/mol shows the vial contains No DAC and not DAC material, and HPLC reports the purity. Find the report using the lot code on your label in our COA library, before or after ordering.

What is the process to buy CJC 1295 No DAC online in Australia?

Add the 10 mg vial to your cart and pay on this page. Any order placed by 3pm on a business day leaves our Australian warehouse with tracking that afternoon, to regional addresses as well as the capitals. No diluent is included, so add bacteriostatic water, and confirm at checkout that you are an adult.